SCHEMBL646329

SCHEMBL646329

CCCCC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1

nearest known ligand 0.59

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HPN P05981 1/20 0.59
▸ MAPT P10636 1/20 0.59
▸ ALOX15 P16050 1/20 0.59
▸ SIRT5 Q9NXA8 1/20 0.59
▸ VCAM1 P19320 10/20 0.44
▸ CA2 P00918 3/20 0.42
▸ CA1 P00915 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.41
▸ POLB P06746 1/20 0.41
▸ TYR P14679 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ PTGS1 P23219 2/20 0.40
▸ PTGS2 P35354 2/20 0.40
▸ LMNA P02545 2/20 0.39
▸ GAA P10253 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ RECQL P46063 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8497146 0.94 HPN (0.56) HPNMAPTALOX15SIRT5VCAM1
SCHEMBL648287 0.90 ALOX15 (0.63) HPNMAPTALOX15SIRT5VCAM1
SCHEMBL647467 0.82 ALOX15 (0.68) HPNMAPTALOX15SIRT5VCAM1
SCHEMBL647768 0.79 ALOX15 (0.63) HPNMAPTALOX15SIRT5VCAM1
SCHEMBL645860 0.79 ALOX15 (0.68) HPNMAPTALOX15SIRT5VCAM1
SCHEMBL648883 0.78 VCAM1 (0.59) HPNMAPTALOX15SIRT5VCAM1
SCHEMBL647898 0.77 ALOX15 (0.59) HPNMAPTALOX15SIRT5VCAM1
SCHEMBL11742489 0.76 HPN (0.50) HPNMAPTALOX15SIRT5VCAM1
SCHEMBL8699143 0.76 HPN (0.53) HPNMAPTALOX15SIRT5VCAM1
SCHEMBL10504856 0.76 ALOX15 (0.63) HPNMAPTALOX15SIRT5VCAM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2070919-B1 SPIROQUINONE COMPOUND AND PHARMACEUTICAL COMPOSITION HYKES LAB LLC (JP) 2012-10-10 — — EP disclosed
US-8119686-B2 Spiroquinone compound and pharmaceutical composition HYKES LABORATORIES LLC (JP) 2012-02-21 — — US disclosed
US-20100056613-A1 SPIROQUINONE COMPOUND AND PHARMACEUTICAL COMPOSITION HYKES LABORATORIES LLC (JP) 2010-03-04 — — US disclosed
EP-2070919-A1 SPIROQUINONE COMPOUND AND PHARMACEUTICAL COMPOSITION Hykes Laboratories LLC (JP) 2009-06-17 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056613-A1 SPIROQUINONE COMPOUND AND PHARMACEUTICAL COMPOSITION NR1H2, NR1H3, APOB HPN 3356/4885MAPT 4362/4885ALOX15 2563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback